A Randomized Trial of Mesenchymal Stromal Cells for Moderate to Severe Acute Respiratory Distress Syndrome from COVID-19Michael E. Bowdish, Annetine C. Gelijns, Nimesh D. Desai et al.|American Journal of Respiratory and Critical Care Medicine|2022Cited by 71